the right inhaler for the right person. There are various problems in administering asthma and COPD treatment to patients. In asthma, for example, people don't necessarily perceive that they have ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Conference Call and Webcast Information Verona Pharma will host an investment community webcast and conference call at 9:00 a.m. EST / 2:00 p.m. GMT on Thursday, February 27, 2025, to discuss the ...

Compared with control patients, invited patients spent less out-of-pocket. Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for ...

COPD comprises ... multiple inhaled medications are prescribed. Additional education, supported by the necessary resources, would help ensure patients are receiving optimal treatment and avoiding ...

COPD headaches may be related to chronic inflammation, oxidative stress, or a buildup of carbon dioxide in your blood. Treatment can involve oxygen therapy and medications like bronchodilators and ...

“The finding that SGLT-2i and GLP-1RAs lower COPD exacerbation risk compared to DPP-4i suggests these medications could be ...

Medscape Medical News, July 03, 2024 US FDA Approves Verona Pharma's Inhaled COPD Therapy The U.S. Food and Drug Administration has granted approval to a treatment from Verona Pharma for a chronic ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

RAs, and DPP-4is may offer benefits for patients with COPD, but clinical evidence comparing their effectiveness in reducing ...